Carlos José Ferreira da Silva

Carlos José Ferreira da Silva

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Carlos Vinicius Ferreira da SilvaCarlos Vinicius Ferreira da Silva
Carlos Vinicius Ferreira da Silva
CSCarlos José Ferreira da Silva
Carlos José Ferreira da Silva
FMFernanda da Silva Marinho
Fernanda da Silva Marinho
YSYoussef Sade
Youssef Sade
SSSandra Mara Naressi Scapin
Sandra Mara Naressi Scapin
ESEidy de Oliveira Santos
Eidy de Oliveira Santos
The rising global prevalence of obesity and related disorders, including metabolic syn-drome (MetS) and type 2 diabetes (T2DM), highlights the need to better understand the mechanisms underlying these conditions, particularly host–microbiota interactions. While the gut microbiota has been extensively studied, the role of the oral microbiota and its interaction with human salivary proteins remains poorly explored. This study investigated the integrated human salivary proteome and bacterial metaproteome in Brazilian individuals spanning different metabolic states: normal weight, overweight, obesity, MetS, and T2DM. Saliva samples were analyzed using mass spectrome-try-based proteomics to identify differential protein profiles. The results revealed sig-nificant downregulation of the human proteins MYSM1 and GAD65 in obesity, MetS, and T2DM, with negative correlations to BMI, suggesting compromised an-ti-inflammatory functions. In contrast, carbonic anhydrase VI (CA6) was markedly upregulated and positively correlated with systolic blood pressure and glucose levels, indicating an acidic and inflammatory oral environment. In the bacterial metaprote-ome, TrxC-2, UMPK, and RsmH were significantly increased in metabolically com-promised groups and positively associated with anthropometric and insulin resistance markers, reflecting microbial adaptations to oxidative stress and enhanced virulence. Interactome analysis revealed negative correlations between bacterial proteins and MYSM1/GAD65, alongside positive associations with CA6, suggesting a feedback loop between oral dysbiosis and host metabolic dysfunction. These findings highlight the oral cavity as a key site of host–microbiota interaction in metabolic diseases and iden-tify potential biomarkers and therapeutic targets.

14 October 2026 in Biology
Verified
Journal Article
Open access
PDF file
Carlos Vinicius Ferreira da SilvaCarlos Vinicius Ferreira da Silva
Carlos Vinicius Ferreira da Silva
CSCarlos José Ferreira da Silva
Carlos José Ferreira da Silva
TCThais Regiani Cataldi
Thais Regiani Cataldi
LALabate Carlos Alberto
Labate Carlos Alberto
YSYoussef Sade
Youssef Sade
ESEidy de Oliveira Santos
Eidy de Oliveira Santos
Metabolic Syndrome (MetS) includes a complex cluster of metabolic disorders that significantly increases the risk for cardiovascular disease and Type 2 Diabetes Mellitus. This study aimed to elucidate the molecular architecture and systemic burden of MetS by integrating high-resolution plasma proteomics, metabolomics, and lipidomics. A cohort of 60 adult volunteers (n = 37 controls; n = 23 MetS) from Brazil was subjected to comprehensive clinical evaluation and multi-omics profiling. Clinical analysis identified HOMA-IR and triglycerides as primary predictors of MetS. FDR was used for multiple testing correction for all data. Untargeted proteomics identified 589 proteins, with 26 showing significant differential abundance, including the upregulated Intercellular Adhesion Molecule-1 (ICAM-1) and Vanin-1 and the depleted protective Apolipoprotein D (ApoD) in MetS. Metabolomic analysis resulted in the identification of 410 metabolites, with 27 distinct features, revealing accumulation of branched-chain and aromatic amino acids, alongside a significant reduction in the signaling molecule 3-hydroxybutyrate, in the case group. Lipidomic profiling identified 1241 lipids, with 41 differentially abundant, highlighting the increase in Phosphatidylinositol (PI 40:5) and Phosphatidylcholine (PC) classes and the depletion of Sphingomyelins (SM). Integrative analysis demonstrated that MetS comprises a synchronized and multisystemic molecular disruption rather than a collection of independent risk factors. The homeostatic breakdown is characterized by the depletion of the body’s antioxidant and anti-inflammatory defense, and the elevation of pro-inflammatory mediators like ICAM-1 and Vanin-1, the accumulation of lipotoxic drivers and a significant disruption in amino acid catabolism (BCAA) that overactivates the mTORC1 pathway. These findings provide a multifactorial metabolic dysregulation, offering putative signatures for future diagnoses and risk stratification.

10 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Carlos Vinicius Ferreira da SilvaCarlos Vinicius Ferreira da Silva
Carlos Vinicius Ferreira da Silva
CSCarlos José Ferreira da Silva
Carlos José Ferreira da Silva
TCThais Regiani Cataldi
Thais Regiani Cataldi
LALabate Carlos Alberto
Labate Carlos Alberto
YSYoussef Sade
Youssef Sade
ESEidy de Oliveira Santos
Eidy de Oliveira Santos
Metabolic Syndrome (MetS) is a complex cluster of metabolic disorders that significantly increases the risk for cardiovascular disease and Type 2 Diabetes Mellitus. This study aimed to elucidate the molecular architecture and systemic burden of MetS by integrating high-resolution plasma proteomics, metabolomics, and lipidomics. A cohort of 60 adult volunteers (n=37 controls; n=23 MetS) from Brazil underwent comprehensive clinical evaluation and multi-omics profiling. Clinical analysis identified HOMA-IR and triglycerides as primary predictors of MetS. Untargeted proteomics identified 589 proteins, with 26 showing significant dysregulation, including the upregulation of Intercellular Adhesion Molecule-1 (ICAM-1) and Vanin-1 and the depletion of protective Apolipoprotein D (ApoD). Metabolomic analysis identified 410 metabolites, with 27 distinct features, revealing an accumulation of branched-chain and aromatic amino acids, alongside a significant reduction in the signaling molecule 3-hydroxybutyrate. Lipidomic profiling identified 1,241 lipids, with 41 abundantly different, highlighting a profound remodeling characterized by the increase of Phosphatidylinositol (PI 40:5) and Phosphatidylcholine (PC) classes and the depletion of Sphingomyelins (SM). Integrative analysis demonstrated that MetS comprises a synchronized and multisystemic molecular disruption rather than a collection of independent risk factors. The homeostatic breakdown is characterized by the depletion of the body's antioxidant and anti-inflammatory defense, and the elevation of pro-inflammatory mediators like ICAM-1 and Vanin-1, the accumulation of lipotoxic drivers and a significant disruption in amino acid catabolism (BCAA) that overactivates the mTORC1 pathway. These findings provide a multifactorial map of metabolic dysregulation, offering a robust molecular signature for early diagnosis and the development of personalized therapeutic strategies to mitigate the systemic burden of metabolic disease.

19 August 2026 in Proteomics – Clinical Applications
Verified
Journal Article
Open access
Carlos Vinicius Ferreira da SilvaCarlos Vinicius Ferreira da Silva
Carlos Vinicius Ferreira da Silva
CSCarlos José Ferreira da Silva
Carlos José Ferreira da Silva
FMFernanda da Silva Marinho
Fernanda da Silva Marinho
YSYoussef Sade
Youssef Sade
SSSandra Mara Naressi Scapin
Sandra Mara Naressi Scapin
ESEidy de Oliveira Santos
Eidy de Oliveira Santos
Purpose: The growing prevalence of obesity, MetS, and T2DM highlights the need to better understand host–microbiota interactions. While gut microbiota has been widely investigated, interactions between the oral microbiota and human salivary proteins remain largely unexplored. Experimental Design: This study investigated the integrated human salivary proteome and bacterial secreted metaproteome in Brazilian individuals spanning different metabolic states: normal weight/control, overweight, obesity, MetS, and T2DM. Saliva samples were analyzed using mass spectrometry‐based proteomics to identify differential protein profiles. Results: Key findings revealed significant downregulation of human proteins MYSM1 (eta2 = 0.710, 95% CI: [0.642, 0.825], qadj< 0.001) and GAD65 ( η 2 = 0.478, 95% CI: [0.368, 0.681], qadj < 0.001) in obese, MetS, and T2DM groups, correlating negatively with BMI, waist circumference, and HOMA‐IR, suggesting impaired anti‐inflammatory and endocrine functions that exacerbate metabolic dysregulation. Conversely, carbonic anhydrase VI (CA6) was markedly upregulated ( η 2 = 0.374, 95% CI: [0.274, 0.570], qadj < 0.001), showing positive correlations with systolic blood pressure and glucose levels, indicative of an acidic, inflammatory oral microenvironment linked to chronic low‐grade inflammation. In the bacterial secreted metaproteome, TrxC‐2 ( η 2 = 0.557, 95% CI: [0.501, 0.727], qadj < 0.001), UMPK ( η 2 = 0.629, 95% CI: [0.571, 0.781], qadj < 0.001), and RsmH ( η 2 = 0.772, 95% CI: [0.718, 0.862], qadj 0.001) were significantly elevated in obesity, MetS, and T2DM, positively associated with anthropometric and insulin resistance markers, reflecting microbial adaptations to oxidative stress and enhanced virulence through biofilm formation and RNA biosynthesis. Interactome analysis demonstrated strong negative correlations between bacterial proteins and human proteins (MYSM1, GAD65), alongside positive correlations with CA6, unveiling a vicious cycle, where oral dysbiosis amplifies host inflammation and metabolic dysfunction, while altered human proteins perpetuate microbial imbalance. Conclusions and Clinical Relevance: These findings underscore the pivotal role of host–microbiota interactions in the oral cavity during the pathogenesis of obesity, MetS, and T2DM, highlighting the importance of further elucidating the molecular and functional mechanisms underlying microbiota–host crosstalk in metabolic diseases.